Feed / CATX

Perspective Therapeutics, Inc.

CATX

Healthcare · 3.47 +11.9% today

Isolated · not yet confirmedMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Perspective Therapeutics, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.

Company+11.9% todayVolume comparison unavailable
Market group0 of 9 activeBiotechnology and Medical Devices · unavailable
Disclosed network0 of 3 confirmingNo filing-linked name is confirming now
What would change this read
  • CATX's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if CATX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind CATX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BMYBristol-Myers Squibb CompanypartnerMay 11, 2026

In March 2024, we entered into a clinical trial collaboration with Bristol Myers Squibb to evaluate the safety and tolerability of [ 212 Pb]VMT01 in combination with Bristol Myers Squibb’s checkpoint inhibitor nivolumab in patients with histologically confirm…

LNTHLantheus Holdings, Inc.partnerMay 11, 2026

Option Agreement On January 8, 2024, the Company entered into an option agreement (Option Agreement) with Lantheus whereby Lantheus was granted an exclusive option to negotiate an exclusive, worldwide, royalty- and milestone-bearing right and license to [ 212…

LNTHLantheus Holdings, Inc.investeeMar 16, 2026

Asset Purchase Agreement On January 8, 2024, the Company entered into an Asset Purchase Agreement (Progenics APA) with Progenics Pharmaceuticals, Inc., a Delaware corporation (Progenics) and affiliate of Lantheus, pursuant to which the Company acquired certai…

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CATX is currently a Follower in the organic co-movement group Biotechnology and Medical Devices. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for CATX; it is not active in the latest market snapshot.